Humana Inc (NYSE: HUM) reported Q4 adjusted EPS of $1.62, up from $1.24 a year ago, beating the consensus of $1.46. The company saw a decline in its benefit expense ratio, or the...
Humana (HUM) reported Q4 EPS of $1.62, $0.16 better than the analyst estimate of $1.46. Revenue for the quarter came in at $22.44 billion versus the consensus estimate of $22.48...
Investing.com - Humana (NYSE: HUM) reported fourth quarter EPS of $1.62, $0.16 better than the analyst estimate of $1.46. Revenue for the quarter came in at $22.44B versus the...
As people do not curtail their healthcare expenses even during the roughest economic periods, healthcare stocks have repeatedly proved resilient to recessions.
There is bad news. And there is #$&%!?!-the-stock just-took-a-22%-dive bad news. That was the kind of week it was for shareholders of FedEx (NYSE:FDX). Is the description a...
The increase in global cases of the Delta variant has meant increased volatility for many stocks. Yet, broader indices keep making new highs. So far in the year, the Dow Jones...
Humana Inc. is a health and well-being company. The Company operates through three reportable segments: Retail, Group and Specialty, and Healthcare Services. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts. It also includes its contract to administer the limited income newly eligible transition (LI-NET), prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and long-term support services benefits. The Group and Specialty segment consists of employer group commercial fully insured medical and specialty health insurance benefits marketed to individuals and employer groups, including dental, vision, and other supplemental health benefits, as well as administrative services only products. The Healthcare Services segment includes pharmacy, provider, and home services, along with other services and capabilities to promote wellness and population health.
| Average | 612.29 (+19.82% Upside) |
| High | 662.00 |
| Low | 515.00 |
| Price | 510.99 |
| No. of Analysts | 21 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Buy |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
| Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 1,400.50 | 1,415.50 | 1,381.00 | +12.50 | +0.90% | 705.28K | London | |||
| 1,051.50 | 1,065.50 | 1,040.50 | -6.50 | -0.61% | 2.62M | London | |||
| 105.18 | 106.26 | 103.22 | -0.56 | -0.53% | 36.78M | London | |||
| 1,700.00 | 1,702.00 | 1,700.00 | 0.00 | 0.00% | 0.00 | London | |||
| 244.80 | 246.00 | 244.80 | 0.00 | 0.00% | 0.00 | London | |||
| 1,523.00 | 1,559.00 | 1,493.00 | +18.00 | +1.20% | 240.20K | London | |||
| 752.60 | 759.20 | 751.00 | -0.40 | -0.05% | 1.43M | London | |||
| 1,765.50 | 1,770.00 | 1,732.50 | +38.50 | +2.23% | 1.14M | London | |||
| 166.75 | 166.75 | 166.75 | 0.00 | 0.00% | 0.00 | London | |||
| 3,018.00 | 3,068.00 | 3,006.00 | -23.0 | -0.76% | 1.54M | London | |||
| 237.60 | 243.40 | 233.80 | -1.20 | -0.50% | 1.42M | London | |||
| 95.00 | 98.10 | 94.70 | 0.00 | 0.00% | 1.67M | London | |||
| 110.80 | 111.90 | 110.30 | 0.00 | 0.00% | 2.05M | London | |||
| 891.50 | 899.50 | 865.00 | +19.0 | +2.18% | 684.74K | London | |||
| 26.50 | 26.50 | 26.50 | 0.00 | 0.00% | 0.00 | London |